LXRX
NGSLexicon Pharmaceuticals Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Sunday 20th July 2025
1.23
-0.12 (-8.89%)
Prev Close:1.35
Open:1.36
Bid:1.23
Ask:1.35
52 Week Range
0.282.45
Volume:4,776,844
Mkt Cap:418 M
62
MarketXLS Rank ®
Buy
Price Target
$1.41
+14.6%
Financial Statements
LXRX - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Gain On Sale Of PPE | 2 M | |||||||||
| Gain On Sale Of Security | 0.0 | 7000.0 | ||||||||
| General And Administrative Expense | 143 M | 114 M | 48 M | 32 M | 47 M | 57 M | 64 M | 66 M | 43 M | 24 M |
| Gross Profit Margin (profit Margin After CGS) | 30 M | 1 M | 139000.0 | 298000.0 | 22 M | 319 M | 60 M | 90 M | 83 M | 130 M |
| Impairment Of Capital Assets | 29 M | 4 M | ||||||||
| Interest Expense Non Operating | 13 M | 3 M | 802000.0 | 15 M | 21 M | 21 M | 7 M | 7 M | 7 M | |
| Interest Income Operating | 1 M | |||||||||
| Misc Other Special Charges | 37 M | 8 M | 2 M | 432000.0 | 4 M | 4 M | 4 M | 2 M | 2 M | 572000.0 |
| Net Income (loss) | -200 M | -177 M | -102 M | -88 M | -59 M | 130 M | -121 M | -123 M | -141 M | -5 M |
| Net Income Common Stockholders | -200 M | -177 M | -102 M | -88 M | -59 M | 130 M | -121 M | -123 M | -141 M | -5 M |
| Net Income Continuous Operations | -200 M | -177 M | -102 M | -88 M | -59 M | 130 M | -121 M | -123 M | -141 M | -5 M |
| Net Income Discontinuous Operations | -12 M | -15 M | -34 M | |||||||
| Net Non Operating Interest Income Expense | 5 M | 1 M | -802000.0 | -15 M | -21 M | -21 M | -7 M | -7 M | -7 M | |
| Normalized Income | -200 M | -69 M | ||||||||
| Operating Income | -197 M | -172 M | -101 M | -87 M | -48 M | 141 M | -104 M | -131 M | -137 M | 5 M |
| Operating Income Before Depreciation (EBITDA) | -198 M | -166 M | -99 M | -87 M | -41 M | 148 M | -96 M | -125 M | -132 M | 3 M |
| Operating Expense | 243 M | 173 M | 101 M | 87 M | 204 M | 181 M | 164 M | 220 M | 220 M | -129 M |
| Other Gain Loss From Disposition Of Discontinued Operations | -12 M | -15 M | -34 M | |||||||
| Other Gand A | 143 M | 114 M | 48 M | 32 M | 47 M | 57 M | 64 M | 66 M | 43 M | 24 M |
| Other Impairment Of Capital Assets | 2 M | 29 M | 0.0 | |||||||
| Other Operating Expenses | 16 M | 13 M | 3 M | 0.0 | 2 M | -703000.0 | 6 M | |||
| Rent And Landing Fees | -1 M | -800000.0 | -1 M | -800000.0 | 0.0 | -600000.0 | -500000.0 | 24 M | ||
| Research Expense | 84 M | 59 M | 53 M | 55 M | 154 M | 92 M | 100 M | 152 M | 178 M | 95 M |
| Restructring And Mn A Income | 6 M | |||||||||
| Salaries And Wages | 14 M | 14 M | -133 M | |||||||
| Total Income Available For Interest Expense (EBIT) | -200 M | -169 M | -99 M | -87 M | -44 M | 145 M | -100 M | -129 M | -135 M | 2 M |
| Total Revenues | 6 M | 1 M | 139000.0 | 298000.0 | 23 M | 322 M | 63 M | 92 M | 83 M | 130 M |
| Total Expenses | 244 M | 173 M | 101 M | 87 M | 206 M | 184 M | 166 M | 222 M | 220 M | -129 M |
| Total Revenue | 31 M | 1 M | 139000.0 | 298000.0 | 24 M | 322 M | 63 M | 92 M | 83 M | 130 M |
| Amord | 45 M | 45 M | 45 M | 2 M | 0.0 | -1 M | ||||
| Avgshs | 320 M | 221 M | 166 M | 146 M | 111 M | 106 M | 106 M | 105 M | 104 M | 104 M |
| Avgshsdt | 320 M | 221 M | 166 M | 146 M | 111 M | 117 M | 106 M | 105 M | 104 M | 116 M |
| Basiceps | -0.63 | -0.8 | -0.62 | -0.6 | -0.53 | 1.23 | -1.14 | -1.17 | -1.36 | 0.84 |
| Basicepscont | -0.63 | -0.8 | -0.62 | -0.6 | -0.53 | 1.23 | -1.14 | -1.17 | -1.36 | |
| Cor | 616000.0 | 85000.0 | 2 M | 3 M | 2 M | 2 M | ||||
| Dileps | -0.63 | -0.8 | -0.62 | -0.6 | -0.53 | 1.16 | -1.14 | -1.17 | -1.36 | -0.05 |
| Dilepscont | -0.63 | -0.8 | -0.6 | -0.53 | 1.16 | -1.14 | ||||
| Netincdisc | -200 M | -177 M | -102 M | -88 M | -59 M | 130 M | -121 M | -123 M | -141 M | -5 M |
| Othincexp | -37 M | -8 M | -2 M | -432000.0 | -3 M | -4 M | -4 M | -2 M | -2 M | -572000.0 |
| Othspecchg | -355000.0 | -178000.0 | ||||||||
| Pretaxinc | -200 M | -177 M | -102 M | -88 M | -59 M | 124 M | -121 M | -136 M | -141 M | -5 M |
| Resdev | 84 M | 59 M | 53 M | 55 M | 154 M | 92 M | 100 M | 152 M | 178 M | 95 M |
| Restruct | 6 M | |||||||||
| Sga | 143 M | 114 M | 48 M | 32 M | 47 M | 57 M | 64 M | 66 M | 43 M | 24 M |
| Shsout | 361 M | 246 M | 189 M | 363 M | 144 M | 107 M | 106 M | 106 M | 104 M | 104 M |
| Specincchg | -5 M | -29 M | 355000.0 | 178000.0 | -4 M | |||||
| Taxprov | -5 M | -269000.0 | -6 M | -115000.0 | -13 M |